Follow the people · Insider
Douglas Carr
Douglas Carr files insider transactions with the SEC as a svp finance & operations of Century Therapeutics (IPSC). We hold 7 disclosed purchases and sales filed since 27 January 2022, 2 of them in the last 90 days.
- Files forIPSC
- Disclosed buys and sells7 in all, 2 in the last 90 days
- Last disclosure5 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 25 January 2022 — 3 August 2026SVP Finance & Operations · Century Therapeutics (IPSC)40 Form 4 lines · source: SEC Form 4
Everything they disclosed
40 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 275 shares of Century TherapeuticsSEC Form 45 August 2026Common Stock · traded 3 August 2026 · filed 5 August 2026
- ▼ sold on the open market 1,654 shares of Century TherapeuticsSEC Form 415 June 2026Common Stock · traded 12 June 2026 · filed 15 June 2026
- ▼ sold on the open market 249 shares of Century TherapeuticsSEC Form 49 June 2026Common Stock · traded 8 June 2026 · filed 9 June 2026
- ▼ sold on the open market 264 shares of Century TherapeuticsSEC Form 46 May 2026Common Stock · traded 4 May 2026 · filed 6 May 2026
- ▼ sold on the open market 7,043 shares of Century TherapeuticsSEC Form 416 March 2026Common Stock · traded 12 March 2026 · filed 16 March 2026
- ▼ sold on the open market 7,043 shares of Century TherapeuticsSEC Form 416 March 2026Common Stock · traded 12 March 2026 · filed 16 March 2026
- ▼ sold on the open market 247 shares of Century TherapeuticsSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 247 shares of Century TherapeuticsSEC Form 411 March 2026Common Stock · traded 9 March 2026 · filed 11 March 2026
- ▼ sold on the open market 323 shares of Century TherapeuticsSEC Form 45 February 2026Common Stock · traded 3 February 2026 · filed 5 February 2026
- ▼ sold on the open market 323 shares of Century TherapeuticsSEC Form 45 February 2026Common Stock · traded 3 February 2026 · filed 5 February 2026
- was granted 110,000 shares of Century TherapeuticsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- was granted 225,000 shares of Century Therapeutics (a derivative holding)SEC Form 44 February 2026Stock Option (right to buy) · traded 2 February 2026 · filed 4 February 2026
- was granted 225,000 shares of Century Therapeutics (a derivative holding)SEC Form 44 February 2026Stock Option (right to buy) · traded 2 February 2026 · filed 4 February 2026
- was granted 110,000 shares of Century TherapeuticsSEC Form 44 February 2026Common Stock · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 257 shares of Century TherapeuticsSEC Form 410 December 2025Common Stock · traded 8 December 2025 · filed 10 December 2025
- ▼ sold on the open market 292 shares of Century TherapeuticsSEC Form 45 November 2025Common Stock · traded 3 November 2025 · filed 5 November 2025
- ▼ sold on the open market 263 shares of Century TherapeuticsSEC Form 410 September 2025Common Stock · traded 8 September 2025 · filed 10 September 2025
- ▼ sold on the open market 296 shares of Century TherapeuticsSEC Form 46 August 2025Common Stock · traded 4 August 2025 · filed 6 August 2025
- ▼ sold on the open market 4,904 shares of Century TherapeuticsSEC Form 411 June 2025Common Stock · traded 9 June 2025 · filed 11 June 2025
- ▼ sold on the open market 295 shares of Century TherapeuticsSEC Form 47 May 2025Common Stock · traded 5 May 2025 · filed 7 May 2025
- was granted 95,625 shares of Century Therapeutics (a derivative holding)SEC Form 412 March 2025Stock Option (right to buy) · traded 11 March 2025 · filed 12 March 2025
- ▼ sold on the open market 1,240 shares of Century TherapeuticsSEC Form 412 March 2025Common Stock · traded 10 March 2025 · filed 12 March 2025
- was granted 95,625 shares of Century TherapeuticsSEC Form 412 March 2025Common Stock · traded 11 March 2025 · filed 12 March 2025
- ▼ sold on the open market 351 shares of Century TherapeuticsSEC Form 45 February 2025Common Stock · traded 3 February 2025 · filed 5 February 2025
- had shares withheld for tax on 16,611 shares of Century TherapeuticsSEC Form 45 November 2024Common Stock · traded 1 November 2024 · filed 5 November 2024
- ▼ sold on the open market 283 shares of Century TherapeuticsSEC Form 45 November 2024Common Stock · traded 4 November 2024 · filed 5 November 2024
- ▼ sold on the open market 289 shares of Century TherapeuticsSEC Form 47 August 2024Common Stock · traded 5 August 2024 · filed 7 August 2024
- was granted 17,007 shares of Century TherapeuticsSEC Form 410 June 2024Common Stock · traded 7 June 2024 · filed 10 June 2024
- ▼ sold on the open market 257 shares of Century TherapeuticsSEC Form 47 May 2024Common Stock · traded 3 May 2024 · filed 7 May 2024
- was granted 81,000 shares of Century Therapeutics (a derivative holding)SEC Form 411 March 2024Stock Option (right to buy) · traded 7 March 2024 · filed 11 March 2024
- was granted 14,000 shares of Century TherapeuticsSEC Form 411 March 2024Common Stock · traded 7 March 2024 · filed 11 March 2024
- ▼ sold on the open market 643 shares of Century TherapeuticsSEC Form 47 February 2024Common Stock · traded 5 February 2024 · filed 7 February 2024
- ▼ sold on the open market 557 shares of Century TherapeuticsSEC Form 47 February 2024Common Stock · traded 6 February 2024 · filed 7 February 2024
- had shares withheld for tax on 16,611 shares of Century TherapeuticsSEC Form 43 November 2023Common Stock · traded 1 November 2023 · filed 3 November 2023
- was granted 120,846 shares of Century TherapeuticsSEC Form 417 May 2023Common Stock · traded 15 May 2023 · filed 17 May 2023
- was granted 45,000 shares of Century Therapeutics (a derivative holding)SEC Form 46 February 2023Stock Option (right to buy) · traded 2 February 2023 · filed 6 February 2023
- was granted 45,000 shares of Century Therapeutics (a derivative holding)SEC Form 46 February 2023Stock Option (right to buy) · traded 2 February 2023 · filed 6 February 2023
- was granted 7,500 shares of Century TherapeuticsSEC Form 46 February 2023Common Stock · traded 2 February 2023 · filed 6 February 2023
- was granted 7,500 shares of Century TherapeuticsSEC Form 46 February 2023Common Stock · traded 2 February 2023 · filed 6 February 2023
- was granted 35,000 shares of Century Therapeutics (a derivative holding)SEC Form 427 January 2022Stock Option (right to buy) · traded 25 January 2022 · filed 27 January 2022
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.